B/BE/21/BVW7 - Information sheet for the public (prepared by the notifier)

File: 
PDF icon bbe21bvw7_pub_en.pdf
Trial reference: 
Phase I open-label, dose escalation trial of BI 1831169 monotherapy and in combination with ezabenlimab in patients with advanced or metastatic solid tumors
Doc type: 
Information for the public